Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months

• Published in: Translational oncology Vol. 28; p. 101614
• Main Authors: Deng, Yuwei, Ma, Jianli, Zhao, Shu, Yang, Ming, Sun, Yutian, Zhang, Qingyuan
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2023; Neoplasia Press; Elsevier
• Subjects: Follicular lymphoma; GLUT1; Original Research; PI3K/Akt /mTOR signaling; POD24; Tumor-infiltrating immunocytes; GLUT1; PI3K/Akt /mTOR signaling; FL; Follicular lymphoma; Tumor-infiltrating immunocytes; MIBI-TOF; POD24; TME
• ISSN: 1936-5233; 1936-5233
• DOI: 10.1016/j.tranon.2022.101614

•Overexpressing GLUT1 was related to progression of disease within 24 months in FL.•Tumor cells with overexpressed GLUT1 could induce more suppressive immunocytes in FL.•Suppressive immunocytes in turn promoted tumor progression within 24 months in FL.•Spatial immunophenotypes could well predict tumor progression within 24 months in FL.•Suppressive immunocytes activated tumor PI3K/ Akt /mTOR pathway in later stage of FL. Follicular lymphoma (FL) occurring progression within 24 months (POD24) after initial immunochemotherapy has poor prognosis. GLUT1 affects glycolysis within tumor microenvironment (TME) and promotes tumor progression. However, its specific mediated mechanism remains unclear in FL. Baseline GLUT1 expression, infiltrations of M2 macrophage, and CD8+ T-cells were assessed by immunohistochemistry in FL with POD24 and long-term remission respectively. The spatial features of TME were assessed by MIBI-TOF and proteomics. Predictive immunophenotypes for POD24 occurrence was analyzed by random forest algorithm. The lactate production and the induction of M2 macrophages were detected when GLUT1 was transfected or knocked down in DOHH2. The activation of PI3K/Akt/mTOR signaling in DOHH2 and WSU-FSCCL cells co-cultured with induced inhibitory immunocytes was tracked by western blotting. The FL with POD24 exhibited higher baseline GLUT1 expression and increased infiltration of various inhibitory immunocytes. Spatial signatures of 69 immunophenotypes could predict POD24 occurrence. The activation of PI3K/ Akt /mTOR signaling pathway was not significant in both groups. The supernatant of DOHH2-GLUT1 cells which had more lactate content could induce more M2-type macrophages than that of DOHH2/siRNA GLUT1 cells. When co-cultured with exhausted CD8+ T cells, M2-type macrophages and Tregs, compared with WSU-FSCCL cells, DOHH2 cells with high GLUT1 expression induced more M2-type macrophages and was triggered activation of PI3K/ Akt /mTOR signaling pathway. Tumor cells overexpressing GLUT1 could domesticate immunocytes to form an immunosuppressive TME, which promotes occurrence of POD24 and gradually activates PI3K/ Akt /mTOR pathway of tumor cells in FL. Tumor cells overexpressing GLUT1 could domesticate immunocytes to form an immunosuppressive microenvironment, which in turn promoted the growth of tumor cells and was related to the progression of disease within 24 months in FL. Suppressive immunocytes gradually activated PI3K/ Akt /mTOR pathway of tumor cells in later stage. Distinguishing spatial features of immunocytes could well predict POD24 occurrence, hoping to benefit these patients from early anti-metabolism therapy based on GLUT1 in the future.